✦ LIBER ✦

Immunomodulatory treatment strategies in multiple sclerosis

✍ Scribed by Bernd C. Kieseier; Heinz Wiendl; Verena I. Leussink; Olaf Stüve

Publisher: Springer
Year: 2008
Tongue: English
Weight: 171 KB
Volume: 255
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-008-6004-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current issues in immunomodulatory treat

Current issues in immunomodulatory treatment of multiple sclerosis

✍ Martin Stangel; Ralf Gold; Achim Gass; Judith Haas; Stefan Jung; Wolfgang Elias; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 234 KB

Cancer incidence in multiple sclerosis a

Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments

✍ Anat Achiron; Yoram Barak; Mitchell Gail; Matilda Mandel; David Pee; Rajeev Ayya 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 191 KB

Basic and escalating immunomodulatory tr

Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations

✍ Multiple Sclerosis Therapy Consensus Group (MSTCG); H. Wiendl; K. V. Toyka; P. R 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 335 KB

On cancer incidence in multiple sclerosi

On cancer incidence in multiple sclerosis and effects of immunomodulatory treatments

✍ Paul D. Feigin 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 119 KB

Immunomodulatory medicines for multiple

Immunomodulatory medicines for multiple sclerosis: Progress and prospects

✍ Alan M. Palmer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

## Abstract Multiple sclerosis (MS) is a neurodegenerative disease with a major inflammatory component that constitutes the most common progressive and disabling neurological condition in young adults. Current therapies are mainly biological agents (β‐interferons, a 4‐amino acid peptide, and a mono

Prevention strategies for multiple scler

Prevention strategies for multiple sclerosis

✍ Dr Stephen L. Hauser 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB